MPN

An Ocean of Hope For MPN Research

September 12, 2013
Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. We’re posting a story about one of the participants in 23andMe’s MPN Research Initiative...
Read More

Top Genetic Findings of 2012

December 20, 2012
Take a moment to look back at the ten most interesting and significant genetic findings of 2012 or at least the ones that drew our attention. In the last 12...
Read More

Novel Genetic Findings for Myeloproliferative Neoplasms

October 12, 2012
Dave Hinds is a Principal Scientist in Statistical Genetics.   Editor’s note: This post has been edited from its original to reflect changes in 23andMe’s product. 23andMe is passionate about...
Read More

A Milestone in the Fight Against MPNs Marks a Moment to Reflect

October 01, 2012
Ashley Gould, 23andMe’s Vice President Corporate Development and Chief Legal Officer We recently topped our goal of enrolling 1,000 people with a group of rare blood disorders known as myeloproliferative...
Read More

Fighting Rare Blood Cancers

September 04, 2012
Dr. Ross Levine Last year 23andMe launched a Myeloproliferative Neoplasms Research Initiative to study this group of rare blood cancers. We are now very close to reaching our goal of...
Read More

23andMe Partnering with Patients

May 29, 2012
By Meghan Mullins Before joining 23andMe, I worked at a more traditional genetic research lab. Like virtually all research centers, we didn’t return genetic results to our research participants. I...
Read More

National Cancer Research Awareness Month

May 11, 2012
Cancer is not one disease, but many, and this has been one of the most challenging aspects of researching cures for cancer. 23andMe is applying its unique research platform to study cancer with research communities focused on sarcoma, myeloproliferative neoplasms, and metastatic breast cancer. Patients from all over the world can contribute directly to research and connect with others who have their disease, all while learning more about themselves.
Read More

Silver Linings in Rare Disease

March 07, 2012
Luck is not the word you typically associate with a cancer diagnosis or even a heightened risk of cancer, but some people can see a silver lining even in the...
Read More

SNPwatch: The Jist on JAK2 and Myeloproliferative Neoplasms

March 05, 2012
Myeloproliferative neoplasms (MPN) are a group of rare blood disorders. First characterized in 1951, it wasn't until 2005 that researchers began to uncover clues about the genetic basis of these diseases. An acquired mutation called V617F in the JAK2 gene is present in many people with MPN, and a growing body of research -- including evidence in 23andMe's MPN research cohort -- suggests that relatively common inherited genetic variants may predispose individuals to V617F-positive MPN.
Read More

Thank You For Helping to Fight Rare Disease!

March 02, 2012
On Monday we kicked off a campaign for Rare Disease Day to raise awareness of research, especially into two rare diseases, myeloproliferative neoplasms (MPN) and sarcoma. We hoped to reach...
Read More